Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medius Holdings CoTSE:3154 58 ROE % is 5.52% as of Dec. 2025, which is 29% below its 10-year median of 7.81. GuruFocus rates TSE:3154 with a GF Score™ of 58/100 and a GF Value™ of 円1,009.31 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 799 Medical Devices & Instruments companies, Medius Holdings Co ranks better than 56.32% on this metric.
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Dec. 2025) net income data. The Revenue data used here is four times the quarterly (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
Medius Holdings Co ROE % Related Terms
Medius Holdings Co ROE % Historical Data
* Premium members only.
The historical data trend for Medius Holdings Co's ROE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Medius Holdings Co's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medius Holdings Co ROE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Medius Holdings Co's ROE % distribution charts can be found below:
* The bar in red indicates where Medius Holdings Co's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
ROE % is displayed in the 30-year financial page.
Medius Holdings Co (TSE:3154) has a ROE % of 5.52% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medius Holdings Co and its competitors. This is 29% below median its historical median of 7.81. According to the industry distribution chart, Medius Holdings Co ranks #349 out of 799 companies in the Medical Devices & Instruments industry, placing it in the top 43.7%.
Is Medius Holdings Co's ROE % too high?
Medius Holdings Co's current ROE % of 5.52% is 29% below median its 10-year median of 7.81. The Medical Devices & Instruments industry median ROE % is 2.75. Medius Holdings Co's value of 5.52% is 100.7% above this industry median. Based on the distribution chart, Medius Holdings Co ranks #349 out of 799 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Medius Holdings Co has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medius Holdings Co's ROE % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Medius Holdings Co ranks #349 out of 799 companies for ROE %. This puts Medius Holdings Co in the upper half of its industry. The industry median ROE % is 2.75. Medius Holdings Co's value of 5.52% is 100.7% above this benchmark. While the company's 10-year median is 7.81 vs. the industry median of 2.75, Medius Holdings Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Medical Devices & Instruments company?
The median ROE % among Medical Devices & Instruments companies is 2.75, based on 799 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medius Holdings Co's current ROE % of 5.52% is 100.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Medius Holdings Co and its competitors. For the Medical Devices & Instruments industry, the median ROE % is 2.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medius Holdings Co's current ROE % is 5.52%, which is 29% below median its own 10-year median of 7.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medius Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Medius Holdings Co (TSE:3154) is currently considered Modestly Undervalued. The stock's GF Value™ is 円1,009.31, compared to a current price of 円780.00 — trading 22.7% below its estimated fair value. The current ROE % is 5.52%, which is 29% below median its 10-year median of 7.81 and 100.7% above the Medical Devices & Instruments industry median of 2.75. Medius Holdings Co's overall GF Score™ is 58/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Medius Holdings Co (TSE:3154), the current ROE % is 5.52% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medius Holdings Co (TSE:3154) Overvalued in 2026?
Based on GuruFocus' analysis, Medius Holdings Co stock appears to be undervalued.
The current stock price of 円780.00 is trading 22.7% below its estimated GF Value™ of 円1,009.31.
GuruFocus considers Medius Holdings Co to be Modestly Undervalued.
Key valuation signals for TSE:3154:
ROE %: 5.52% (29% below median its 10-year median of 7.81)
GF Value™: 円1,009.31 vs. price of 円780.00 (22.7% below fair value)
Industry Position: 100.7% above the Medical Devices & Instruments median (#349 of 799)
No single metric tells the full story. See the TSE:3154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medius Holdings Co Ltd is engaged in the healthcare sector. The company's business division includes Medical equipment sales business, Care and welfare business, and Solution business. The Medical equipment sales business offers syringes and gloves to surgical assistance along with repairs and maintenance of medical equipment, and The care and welfare business provides transfer equipment and electric powdered beds. The company's segments include: Medical equipment sales business; and Nursing care and welfare business. It derives maximum revenue from Medical equipment sales business.
58GF Score
Get the complete analysis for TSE:3154
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:3154 has been successfully added to your 
